ERSP case
This article was originally published in The Rose Sheet
Executive Summary
1-800-Pharmacy has failed to respond to an inquiry by the Electronic Retailing Self-Regulation Program regarding core claims made in Web site advertising for OHT Peptide-3 Anti-Aging System, watchdog group says July 13. Claims at issue include "contains the exact, clinically tested dosage of each ingredient. This potency ensures that OHT Peptide-3 delivers efficacious results"; "results correspond to a restructuring of the tissue"; and "Experience OHT Peptide-3's Safe, Botox-like Effects," according to ERSP. 1-800-Pharmacy must submit substantiation for the core claims in 10 days, ERSP notes, adding failure to respond will result in referral of the case to the Federal Trade Commission...